EverQuote, Inc.·4

Sep 29, 4:58 PM ET

Graham Nicholas 4

4 · EverQuote, Inc. · Filed Sep 29, 2021

Insider Transaction Report

Form 4
Period: 2021-09-27
Graham Nicholas
Chief Revenue Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-09-276,00018,000 total
    Exercise: $7.25Exp: 2028-01-23Class A Common Stock (6,000 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2021-09-27$10.42/sh+6,262$65,25059,370 total
  • Exercise/Conversion

    Class A Common Stock

    2021-09-27$10.42/sh+405$4,22059,775 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-09-276,2621,333 total
    Exercise: $10.42Exp: 2028-04-30Class A Common Stock (6,262 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2021-09-27$7.25/sh+6,000$43,50053,108 total
  • Sale

    Class A Common Stock

    2021-09-27$20.02/sh20,308$406,56639,467 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-09-274050 total
    Exercise: $10.42Exp: 2028-04-30Class A Common Stock (405 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2021, as amended on August 13, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.13, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
  • [F3]The shares underlying the option vested and became exercisable as to 25% of the shares underlying the option on January 24, 2019 and became or become exercisable in equal monthly installments over the following 36 months.
  • [F4]The shares underlying the option became or become exercisable in equal monthly installments over the 48 months following May 31, 2018.
  • [F5]The shares underlying the option became exercisable on December 31, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION